Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
The study “Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy,” published in Nature Medicine (2003), investigated benfotiamine, a lipid-soluble form of thiamine (vitamin B1), and its ability to prevent diabetic retinopathy by simultaneously inhibiting three harmful metabolic pathways activated by high blood sugar—the hexosamine, DAG-PKC,
June 26, 2025
No Comments